Surgical resection of hepatic metastases

Interventional Oncology: Principles and Practice

Volumn , Issue , 2008, Pages 243-248

  Choti, Michael A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84932621143     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511722226.021     Document Type: Chapter

References (37)

1. El-Serag HB and Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med, 1999 Mar 11; 340(10): 745-750.
2. DeOliveira ML, Cunningham SC, Cameron JL, et al. Cholangiocarcinoma: Thirty-one-year experience with 564 patients at a single institution. Ann Surg, 2007 May; 245(5): 755-762.
3. Mor E, Kaspa RT, Sheiner P, et al. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med, 1998 Oct 15; 129(8): 643-653.
4. Farmer DG, Rosove MH, Shaked A, et al. Current treatment modalities for hepatocellular carcinoma. Ann Surg, 1994 Mar; 219(3): 236-247.
5. Jemal A, Murray T, Ward E, et al. Cancer Statistics, 2005. CA Cancer J Clin, 2005; 55: 10-30.
6. Steele G, Jr and Ravikumar TS. Resection of hepatic metastases from colorectal cancer: Biologic perspective. Ann Surg, 1989; 210: 127-138.
7. Capussotti L and Polastri R. Operative risks of major hepatic resections. Hepatogastroenterology, 1998; 45: 184-190.
8. Sitzmann JV and Greene PS. Perioperative predictors of morbidity following hepatic resection for neoplasm: A multivariate analysis of a single surgeon's experience with 105 patients. Ann Surg, 1994; 219: 13-17.
9. Belghiti J, Hiramatsu K, Benoist S, et al. Seven hundred forty-seven hepatectomies in the 1990s: Anupdate to evaluate the actual risk of liver resection. J Am Coll Surg, 2000; 191: 38-46.
10. Farges O, Malassagne B, Flejou JF, et al. Risk of major liver resection in patients with underlying chronic liver disease: A reappraisal. Ann Surg, 1999; 229(2): 210-215.
11. Kokudo N, Imamura H, Sugawara Y, et al. Surgery for multiple hepatic colorectal metastases. J Hepatobiliary Pancreat Surg, 2004; 11: 84-91.
12. Weber SM, Jarnagin WR, DeMatteo RP, et al. Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol, 2000; 7: 643-650.
13. Iwatsuki S, Dvorchik I, Madariaga JR, et al. Hepatic resection for metastatic colorectal adenocarcinoma: A proposal of a prognostic scoring system. J AmColl Surg, 1999; 189: 291-299.
14. Abdalla EK, Denys A, Chevalier P, et al. Total and segmental liver volume variations: Implications for liver surgery. Surgery, 2004 Apr; 135(4): 404-410.
15. Yigitler C, Farges O, Kianmanesh R, et al. The small remnant liver after major liver resection: How common and how relevant? Liver Transpl, 2003 Sep; 9(9): S18-25.
16. Abdalla EK, Hicks ME, and Vauthey JN. Portal vein embolization: Rationale, technique and future prospects. Br J Surg, 2001; 88: 165-175.
17. Khatri VP, Petrelli NJ, and Belghiti J. Extending the frontiers of surgical therapy for hepatic colorectal metastases: Is there a limit? J Clin Oncol, 2005 Nov 20; 23(33): 8490-8499.
18. Farges O, Malassagne B, Flejou JF, et al. Risk of major liver resection in patients with underlying chronic liver disease: A reappraisal. Ann Surg, 1999; 229(2): 210-215.
19. Lee CS, Sheu JC, Wang M, et al. Long-term outcome after surgery for asymptomatic small hepatocellular carcinoma. Br J Surg, 1996; 83(3): 330-333.
20. Vauthey JN, Klimstra D, Franceschi D, et al. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg, 1995; 169.
21. Poon RT, Fan ST, Lo CM, et al. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: Implications for a strategy of salvage transplantation. Ann Surg, 2002 Mar; 235(3): 373-382.
22. Choti MA, Bowman HM, Pitt HA, et al. Should hepatic resections be performed at high-volume referral centers? J Gastrointest Surg, 1998; 2: 11-20.
23. Poon RT, Fan ST, Lo CM, et al. Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: Impact on long-term survival. Ann Surg, 2007 Jan; 245(1): 51-58.
24. Scheele J, Stang R, Altendorf-Hofmann A, et al. Resection of colorectal liver metastases. World J Surg, 1995; 19: 59-71.
25. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg, 1999; 230: 309-318; discussion 318-321.
26. Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in longterm survival following liver resection for hepatic colorectal metastases. Ann Surg, 2002; 235: 759-766.
27. Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol, 1997; 15: 938-946.
28. Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg, 2005; 241: 715-722, discussion 722-714.
29. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg, 2004; 239: 818-825.
30. Fernandez FG, Drebin JA, Linehan DC, et al. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg, 2004; 240: 438-447.
31. Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie. Cancer, 1996; 77: 1254-1262.
32. Pawlik TM, Abdalla EK, Ellis LM, et al. Debunking dogma: Surgery for four or more colorectal liver metastases is justified. J Gastrointest Surg, 2006 Feb; 10(2): 240-248.
33. Chen H, Hardacre JM, Uzar A, et al. Isolated liver metastases from neuroendocrine tumors: Does resection prolong survival? J Am Coll Surg, 1998 Jul; 187(1): 88-92.
34. Harrison LE, Brennan MF, Newman E, et al. Hepatic resection for noncolorectal, nonneuroendocrine metastases: A fifteen-year experience with ninety-six patients. Surgery, 1997; 121: 625-632.
35. Benevento A, Boni L, Frediani L, et al. Result of liver resection as treatment for metastases from noncolorectal cancer. J Surg Oncol, 2000 May; 74(1): 24-29.
36. Chen H, Pruitt A, Nichol TL, et al. Complete hepatic resection of metastases from leiomyosarcoma prolongs survival. J Gastrointest Surg, 1998; 2(2): 151-155.
37. Adam R, Chiche L, Aloia T, et al. Hepatic resection for noncolorectal nonendocrine liver metastases: Analysis of 1, 452 patients and development of a prognostic model. Ann Surg, 2006 Oct; 244(4): 524-535.